Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Sensorion Files Confidentially for Potential U.S. IPO - European Biotechnology Magazine

Summary by European-biotechnology.com
The French hearing-loss biotech has taken the first formal step toward a potential U.S. listing, as it advances its remaining gene therapy program into the clinic.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

L'AGEFIL'AGEFI

Sensorion Prepares to Take Stock in the United States

Biotech has just filed its draft registration document with the SEC. Cotted in Paris since 2015, the company has reached a lower historical level. It now capitalizes only EUR 100 million.

Read Full Article
european-biotechnology.comeuropean-biotechnology.com

Sensorion files confidentially for potential U.S. IPO - European Biotechnology Magazine

The French hearing-loss biotech has taken the first formal step toward a potential U.S. listing, as it advances its remaining gene therapy program into the clinic.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

european-biotechnology.com broke the news on Wednesday, September 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Biotech icon

Biotech

Initial Public Offering (IPO) icon

Initial Public Offering (IPO)

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal